MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...

"We are fully committed to bringing this breakthrough drug to patients as quickly as possible while backing everything we do ...

Bayer on Tuesday said it had applied for marketing authorization with the European Medicines Agency (EMA) for its menopause ...

It was unclear what role Bubeck would assume at the Microsoft-backed AI startup. "Sebastian has decided to leave Microsoft to ...

Welcome to Edition 7.15 of the Rocket Report! It's a big week for big rockets, with SpaceX potentially launching its next ...

Conference presentation delivers preclinical results demonstrating Ketamir-2 achieves 100% reversal of neuropathic pain MIAMI, FL / ACCESSWIRE / September 27, 2024 / MIRA Pharmaceuticals ...

SAN DIEGO (KGTV) — ALDI is expanding its presence in San Diego with a new store set to open in Mira Mesa. The store, located at 9340 Mira Mesa Blvd., will officially open its doors on Thursday ...

OpenAI's Chief Technology Officer Mira Murati is leaving the company — the latest in a string of high-profile departures from the leading AI company. After six-and-a-half years at the company ...

Tim Chiang has given his Hold rating due to a combination of factors reflecting the financial position and prospects of Ironwood Pharmaceuticals. The company, primarily involved in the ...

Erez Aminov, CEO & Chairman of the Board, and Dr. Itzchak Angel, Chief Scientific Advisor for MIRA Pharmaceuticals MIRA, were recently interviewed by Benzinga. MIRA is a pre-clinical biopharma ...

Mira Murati, OpenAI’s chief technology officer, in San Francisco, March 13, 2023. From the San Francisco Business Times. Mira Murati announced on Wednesday that she has resigned from OpenAI ...